BG
MEDP icon

Bahl & Gaynor’s Medpace MEDP Stock Holding History

Bahl & Gaynor’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+396
New +$183K ﹤0.01% 334
2018
Q1 		– Sell
-26,435
Closed -$959K – 408
2017
Q4 		$959K Buy
26,435
+435
+2% +$15.2K 0.01% 282
2017
Q3 		$829K Buy
26,000
+4,085
+19% +$125K 0.01% 278
2017
Q2 		$635K Sell
21,915
-13,385
-38% -$375K 0.01% 308
2017
Q1 		$1.05M Buy
+35,300
New +$1.14M 0.01% 247

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bahl & Gaynor's MEDP Position: Q2 2026 in Review

Bahl & Gaynor opened a new position in Medpace (MEDP) in Q2 2026: 396 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #334 among its holdings. This is a return to the name: Bahl & Gaynor previously reported a position in MEDP as recently as Q4 2017.

Bahl & Gaynor first reported a position in MEDP in Q1 2017 and has held it in 5 quarters since. The position peaked at $1.05M in Q1 2017. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bahl & Gaynor held 396 shares of Medpace worth $210K as of Q2 2026.
  • Medpace was a new Bahl & Gaynor position in Q2 2026.
  • Medpace made up ﹤0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #334 holding.
  • Bahl & Gaynor first reported a position in Medpace in Q1 2017 and has held it in 5 quarters since.
  • Bahl & Gaynor's Medpace position peaked at $1.05M in Q1 2017.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.